Livafin CP Cream contains Amorolfine 0.25% w/v, an antifungal agent primarily used for the treatment of superficial fungal infections of the skin and nails. Amorolfine belongs to the morpholine class of antifungals and exerts its effect by inhibiting fungal ergosterol biosynthesis, thereby disrupting the cell membrane integrity and leading to fungal cell death. Livafin CP Cream is indicated for the management of dermatophytosis, candidiasis, and other superficial mycoses caused by susceptible fungi. The cream formulation allows for topical application, providing targeted antifungal activity with minimal systemic absorption, reducing the risk of systemic side effects. It is typically applied once or twice daily to the affected area after cleansing and drying the skin. Treatment duration varies depending on the severity and location of the infection but generally continues for 2 to 4 weeks or as directed by a healthcare professional. Patients should avoid contact with eyes and mucous membranes and discontinue use if irritation or hypersensitivity occurs. Livafin CP Cream is contraindicated in individuals with known hypersensitivity to Amorolfine or any component of the formulation. Proper adherence to the prescribed regimen is essential to achieve optimal therapeutic outcomes and prevent recurrence.